| α-MSH | α-melanocyte-stimulating hormone |
| AP-MS | affinity purification–mass spectrometry |
| ARC4 | ankyrin-repeat cluster 4 |
| co-IP | co-immunoprecipitation |
| CRKL | CRK-like proto-oncogene (adaptor protein) |
| EMT | epithelial–mesenchymal transition |
| eNOS | endothelial nitric oxide synthase |
| EphA8 | ephrin type-A receptor 8 |
| GPCR | G-protein-coupled receptor |
| IGF-1 | insulin-like growth factor 1 |
| IKK | IκB kinase |
| IQGAP1 | IQ-motif-containing GTPase-activating protein 1 |
| LLPS | liquid–liquid phase separation |
| LPS | lipopolysaccharide |
| ML/EH | mid-loop/end-helix (SAM-domain interaction surfaces) |
| MSCP | multi-SAM-containing protein |
| NF-κB | nuclear factor-κB |
| NLS | nuclear localization signal |
| NMR | nuclear magnetic resonance |
| NSCLC | non-small-cell lung cancer |
| PARP | poly(ADP-ribose) polymerase |
| PDB | Protein Data Bank |
| PI3K | phosphoinositide 3-kinase |
| PKM2 | pyruvate kinase M2 |
| PMA | phorbol 12-myristate 13-acetate |
| POMC | pro-opiomelanocortin |
| PTM | post-translational modification |
| PxxP | proline-rich motif |
| RTK | receptor tyrosine kinase |
| SAM | sterile alpha motif |
| SAM1 | first SAM domain of SASH1 |
| SAM2 | second SAM domain of SASH1 |
| SAPD | SASH1-associated pigmentary diseases |
| SCI | spinal-cord injury |
| SH2 | SRC-homology-2 domain |
| SH3 | SRC-homology-3 domain |
| SLy | SH3-domain protein expressed in lymphocytes |
| SPIDER | SLy Proteins Associated Disordered Region |
| TAK1 | TGF-β-activated kinase 1 |
| TBI | traumatic brain injury |
| TBM | tankyrase-binding motif |
| TGF-β | transforming growth factor-β |
| TLR4 | Toll-like receptor 4 |
| TNKS2 | tankyrase-2 |
| TRAF6 | TNF receptor-associated factor 6 |
| UV | ultraviolet |
| Y2H | yeast two-hybrid |